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Skin Diseases in Family Medicine: 
Prevalence and Health Care Use
ABSTRACT
PURPOSE Ongoing care for patients with skin diseases can be optimized by 
understanding the incidence and population prevalence of various skin diseases 
and the patient-related factors related to the use of primary, specialty, and alter-
native health care for these conditions. We examined the recent prevalence of 
skin diseases in a defi ned population of family medicine patients, self-reported 
disease-related quality of life, extent and duration of skin disease, and the use of 
health care by patients with skin diseases.
METHODS We undertook a morbidity registry-based epidemiological study to 
determine the prevalence of various skin diseases, using a patient questionnaire 
to inquire about health care use, within a network of family practices in the 
Netherlands with a practice population of approximately 12,000 citizens.
RESULTS Skin diseases accounted for 12.4% of all diseases seen by the participat-
ing family physicians. Of the 857 questionnaires sent to patients registered with 
a skin disease, 583 (68.0%) were returned, and 501 were suitable for analysis. In 
the previous year, 83.4% of the patients had contacted their family physician for 
their skin disease, 17.0% had contacted a medical specialist, and 5.2% had con-
sulted an alternative health care practitioner. Overall, 65.1% contacted only their 
family physician. Patients who reported more severe disease and lower quality of 
life made more use of all forms of health care.
CONCLUSION This practice population-based study found that skin diseases 
account for 12.4% of diseases seen by family physicians, and that some skin 
problems may be seen more frequently. Although patients with more extensive 
skin diseases also obtain care from dermatologists, most patients have their skin 
diseases treated mainly by their family physician. Overall, patients with more 
severe disease and a lower quality of life seek more treatment.
Ann Fam Med 2008;6:349-354. DOI: 10.1370/afm.861.
INTRODUCTION
Ongoing care for people with skin diseases can be optimized by understanding the incidence and population prevalence of vari-ous skin diseases and the patient-related factors (eg, disease 
severity, psychosocial well-being) related to the use of primary, specialty, 
and alternative health care for these conditions. Although skin diseases 
are common among the general population and account for a high per-
centage of all diseases dealt with by family physicians,1-8 recent preva-
lence data are desirable considering the reported increase in the preva-
lence of speciﬁ c skin diseases (eg, atopic dermatitis and carcinoma of the 
skin).9-11 Additionally, the use of health care by patients with skin diseases 
has rarely been investigated.1,2,12
The goal of this study was to examine the prevalence of skin diseases, 
the use of health care by patients with skin diseases, and the relationship 
between this use of health care and disease-related variables (eg, disease 
severity and quality of life). We expected more patients with more severe 
skin diseases and a lower skin-related quality of life to seek more treatment.
Elisabeth W. M. Verhoeven, MSc1
Floor W. Kraaimaat, PhD1
Chris van Weel, PhD2 
Peter C. M. van de Kerkhof, PhD3
Piet Duller, MSc1,3
Pieter G. M. van der Valk, PhD3
Henk J. M. van den Hoogen2
J. Hans J. Bor2
Henk J. Schers, PhD2
Andrea W. M. Evers, PhD1,3
1Department of Medical Psychology, Rad-
boud University Nijmegen Medical Centre, 
Nijmegen, the Netherlands
2Department of Family Practice, Radboud 
University Nijmegen Medical Centre, 
Nijmegen, the Netherlands 
3Department of Dermatology, Radboud 
University Nijmegen Medical Centre, 
Nijmegen, the Netherlands
Conﬂ icts of interest: none reported
CORRESPONDING AUTHOR
Andrea W. M. Evers, PhD
Department of Medical Psychology (840) 
Radboud University Nijmegen
Medical Centre
PO Box 9101, 6500 HB Nijmegen
The Netherlands
a.evers@mps.umcn.nl 
ANNALS OF FAMILY MEDICINE ✦ WWW.ANNFAMMED.ORG ✦ VOL. 6, NO. 4 ✦ JULY/AUGUST 2008
350
SK IN DISEASES IN FAMILY MEDICINE
METHODS 
The Continuous Morbidity Registration 
This research was conducted within the Continuous 
Morbidity Registration (CMR) of the Department 
of Family Practice, Radboud University Nijmegen 
Medical Centre, the Netherlands.13-16 The CMR was 
founded in 1971 and consists of 4 family practices and 
11 family physicians. It records all new episodes of 
diseases encountered by family physicians participating 
in the network. As a diagnosis-based disease registry, 
CMR records diagnoses according to the adapted 
E-list,17,18 which is compatible with the International 
Classiﬁ cation of Health Problems in Primary Care 
(ICHPPC-2).19 In the Netherlands each person is reg-
istered with 1 family physician, who is a gatekeeper to 
access to specialist medical care. This system enables 
the CMR to register referrals to medical specialists, as 
well as the specialist-reported diagnoses. The CMR 
network covers a relatively stable practice population 
of approximately 12,000 citizens, which is represen-
tative in terms of age and sex of the Dutch general 
population. All patients were informed about the use of 
the database and asked to provide written consent.
Prevalence and Incidence
Within the registry we calculated the age- and sex-
speciﬁ c prevalence of the skin diseases seen during a 
5-year period (2002-2006), as well as the incidence (all 
new cases) during the same period.
Use of Health Care
Questionnaires were sent to all registered patients aged 
18 years or older who had commonly encountered skin 
diseases during the 12 months preceding the study. 
The questionnaire was usually not administered near 
the time of a visit to the family physician when the 
skin disease was presumably more active.
Health care use was measured by the number of 
contacts (visits, telephone calls for prescriptions, or 
contact for referrals) with the family physician for skin 
diseases in the previous year. Additionally, we assessed 
the number of contacts with other specialists and 
complementary or alternative medicine practitioners in 
the previous year.
Disease severity was assessed with a validated 9-
item disease severity scale using the Impact of Skin 
Disease on Daily Life (ISDL), a health instrument that 
measures the degree to which 9 parts of the body 
(face, haired head, neck, hands, arms, torso, legs, 
feet, and genitals/anus) were affected by the disease. 
Response categories were on a 4-point Likert scale 
ranging from “not” (1) to “totally” (4).20,21 A total score 
(range, 9-36) for the affected area of the body was cal-
culated by summing the scores of the 9 items.
Physical symptoms of itching, pain, and fatigue 
were assessed with separate visual analogue scales 
(VAS) that measured the mean level of itching, pain, 
and fatigue during the past 4 weeks (0 = no itch-
ing/pain/fatigue; 10 = worst itching/pain/fatigue ever 
experienced).20,21
Disease-related quality of life was measured with 
the Dermatological Life Quality Index.22 Higher scores 
indicate a lower disease-related quality of life.
Disease duration was measured as the self-reported 
time since initial diagnosis in years. Groups were com-
pared using 2-tailed Student’s t tests or Pearson’s χ2.
RESULTS
Prevalence and Incidence
Skin diseases accounted for 12.4% of all diseases seen 
by family physicians in the CMR. By calculating the 
amount of skin diseases as a percentage of all diseases 
instead of the percentage of all patients, it is possible 
to gain a more precise insight into the frequency with 
which physicians encounter a disease. Table 1 shows 
the age- and sex-speciﬁ c prevalence and incidence of 
each skin disease.
Use of Medical Care for Skin Diseases
Of the 857 questionnaires sent, 583 (68.0%) were 
returned, and 501 were suitable for analysis. The mean 
age of these patients was 49.7 years (SD 17.1 years; 
range, 18.5-97.6 years), 60.9% were female, and 7.4%, 
60.9%, and 31.7% had a primary, secondary, and ter-
tiary level of education, representing on average 7, 12, 
and 17 years of formal education, respectively. There 
was no difference by sex between the responders and 
nonresponders, but the responders were signiﬁ cantly 
younger (t = 3.9; P <.01). Patients with the following 
diagnoses returned questionnaires: 41 patients with 
acne vulgaris, 97 with atopic dermatitis, 27 with con-
tact dermatitis, 11 with corns, 67 with dermatitis, 11 
with diseases of sebaceous glands and sweat glands, 
115 with psoriasis, 72 with seborrheic dermatitis, and 
29 with seborrheic keratosis. There were fewer than 
10 respondents with each of the following diagnoses: 
diseases of the nail, sebaceous cyst, benign neoplasm 
of the skin, chronic ulcer, pruritus, diseases of the hair, 
and the different forms of skin carcinoma. The mean 
duration of skin disease was 16.7 years (SD 15.5 years; 
range, 0.1-67.1 years).
Of the 501 patients who returned the question-
naire, 83.4% reported having contacted a family physi-
cian for their skin disease in the previous 12 months 
(62.1% for visits, with a mean of 2.8 ofﬁ ce visits; 46.3% 
for prescriptions, with a mean of 3.1 telephone calls; 
and 9.4% for referral to other specialists, with a mean 
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of 1.4 contacts). Seventeen percent of the patients had 
visited a specialist on average 3.7 times (91.3% visited 
a dermatologist). In addition, 5.2% had visited an alter-
native health care practitioner (on average 8.1 times).
Most patients contacted only their family physician 
(n = 326, 65.1%). Eight patients (1.6%) visited only a 
specialist, and 3 patients (0.6%) visited only an alterna-
tive health care practitioner. Sixty-eight (13.6%) visited 
their family physician and a specialist, and 14 (2.8%) 
visited their family physician and an alternative health 
care practitioner. In addition, 9 (1.8%) patients visited 
their family physician, a specialist, and an alternative 
health practitioner, and 73 (14.6%) did not contact a 
health care practitioner at all during a 12-month period.
Table 2 compares patients who consulted a health 
care practitioner with those who did not. Patients who 
visited their family physician, another specialist, or an 
alternative health care practitioner reported a signiﬁ -
cantly higher disease severity, more severe itching, and 
a lower disease-related quality of life.
DISCUSSION
In accordance with earlier studies,3,4 skin diseases 
accounted for 12.4% of all diseases seen by the par-
ticipating family physicians of the CMR. As expected, 
we found a high prevalence of, for example, psoriasis 
and atopic dermatitis. The CMR used standard age 
ranges and diagnostic categories that enabled compari-
son with earlier population-based data on skin disease 
prevalence in the Netherlands.3,24 These descriptive 
data indicated a possible increase in the prevalence of 
atopic dermatitis, seborrheic dermatitis, psoriasis, dis-
eases of the hair, and seborrheic keratosis.
Regarding the use of medical care, our results indi-
cated that more than 80% of all patients had contacted 
their family physician for their skin disease during the 
previous year. Moreover, 65% were treated only by 
their family physician during this year. Patients with 
more extensive disease, more itching, and a low dis-
ease-related quality of life made the most use of medi-
cal services. These ﬁ ndings are in line with ﬁ ndings 
for other chronic diseases. For example, Stein et al23 
reported that patients with a chronic disease accompa-
nied by severe psychosocial impairments made more 
frequent use of medical care.
Some limitations of the study should be kept in 
mind. Several subgroups of patients with speciﬁ c skin 
diseases were relatively small, which made it impos-
sible to examine severity, quality of life, and medical 
care use for speciﬁ c skin diseases individually. Even so, 
our data suggest that the results about health care use 
did not differ greatly by diagnosis. Future research is 
needed to study the health care use of patients with 
speciﬁ c skin diseases. Although the CMR uses gener-
ally accepted categories for skin disease that are com-
patible with the ICHPPC, the deﬁ nition of dermatitis 
as a heterogeneous group of skin diseases that emerge 
as skin damage in reaction to a toxin may have inﬂ u-
enced the high prevalence for this category. Finally, 
several variables, for example, disease duration and 
the number of visits to different health care practitio-
ners, were assessed through self-report, and we cannot 
exclude a possible recall bias in these measurements.
Because patients with a more severe skin disease 
and a lower quality of life made the most frequent use 
of health care, paying particular attention to patients’ 
physical symptoms and psychosocial impairments 
might have beneﬁ cial consequences for dermatologi-
cal treatment by increasing satisfaction with treatment 
and patient compliance with dermatological interven-
tions.25,26 More research is needed, however, to provide 
insight into the determinants of health care use and the 
effectiveness of current health care facilities in treating 
speciﬁ c skin diseases.
To read or post commentaries in response to this article, see it 
online at http://www.annfammed.org/cgi/content/full/6/4/349.
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Table 1. Skin Disease Incidence and Prevalence, 2002-2006, per 1,000 Patient-Years, by Age and Sex
Skin Disease Total
Male
Total
Female
Total
Male
0-4 y
Female
0-4 y
Male
5-14 y
Female
5-14 y
Male
15-24 y
Female
15-24 y
Acne vulgaris
Incidence 3.2 2.4 4.1 0.4 0.4 5.6 6.6 13.3 17.3
Prevalence 9.6 5.4 13.7 0.4 0.4 7.2 8.6 35.0 66.9
Atopic dermatitis
Incidence 6.1 6.5 5.7 56.4 40.4 7.4 6.2 2.5 8.4
Prevalence 24.8 23.8 25.7 108.9 77.8 49.9 35.0 18.7 40.6
Benign neoplasm
Incidence 17.5 14.0 20.8 1.2 1.7 2.5 4.4 7.9 16.1
Prevalence 17.6 14.0 21.0 1.2 1.7 2.5 4.4 7.9 16.1
Chronic ulcer
Incidence 2.1 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0
Prevalence 2.5 2.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0
Contact dermatitis
Incidence 2.5 1.5 3.5 0.4 0.8 1.1 1.3 2.2 7.1
Prevalence 4.0 2.2 5.8 0.4 0.8 1.1 1.5 3.2 8.7
Corns
Incidence 3.9 3.4 4.4 0.4 0.0 0.4 0.7 2.2 2.2
Prevalence 4.0 3.4 4.5 0.4 0.0 0.4 0.7 2.2 2.2
Dermatitis
Incidence 53.9 44.0 63.4 62.7 61.0 31.2 41.0 30.2 65.3
Prevalence 64.7 53.4 75.3 64.3 61.4 32.6 43.2 31.5 75.5
Diseases of the hair
Incidence 1.5 0.8 2.1 0.4 0.0 0.7 1.3 0.6 2.2
Prevalence 2.5 1.4 3.7 0.4 0.0 0.9 1.3 0.6 2.2
Diseases of the nails
Incidence 6.8 6.0 7.5 2.4 3.4 4.7 9.3 13.3 8.7
Prevalence 6.8 6.1 7.5 2.4 3.4 4.7 9.3 13.3 8.7
Diseases of sebaceous glands and sweat glands
Incidence 1.8 1.5 2.1 1.2 0.4 0.4 2.6 2.5 4.3
Prevalence 1.9 1.6 2.1 1.2 0.4 0.4 2.6 3.2 4.3
Melanoma
Incidence 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0
Prevalence 1.7 1.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0
Pruritus
Incidence 2.1 1.7 2.4 0.0 0.0 1.1 0.9 0.3 0.9
Prevalence 2.2 19 2.5 0.0 0.0 1.1 0.9 0.3 1.2
Psoriasis
Incidence 1.5 1.3 1.6 0.0 0.4 0.4 0.4 1.9 0.9
Prevalence 15.9 15.5 16.4 0.0 0.4 0.9 0.7 3.8 7.7
Sebaceous cyst
Incidence 10.8 11.2 10.4 0.4 0.4 2.5 0.9 6.7 9.3
Prevalence 10.8 11.2 10.4 0.4 0.4 2.5 0.9 6.7 9.3
Seborrheic dermatitis
Incidence 5.8 5.0 6.5 3.6 7.6 3.8 2.4 3.5 5.6
Prevalence 12.9 12.8 13.0 3.6 7.6 5.4 4.0 7.0 9.0
Seborrheic keratosis (wart seborrheic)
Incidence 7.2 6.2 8.1 0.0 0.0 0.2 0.0 0.3 0.3
Prevalence 7.2 6.3 8.1 0.0 0.0 0.2 0.0 0.3 0.3
Squamous cell carcinoma
Incidence 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3
Prevalence 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 1.5
Note: Use of patient-years is necessary in long-term follow-up research because not every patient under study can be observed for the same period (because of death, 
for example). Total number of patient-years in the registry is the sum of the observation period for all observed individuals. In this case, each month within the 5-year 
period a patient could be observed counts for 1/12 patient year in the total number of patient years in the network.
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Male
25-44 y
Female
25-44 y
Male
45-64 y
Female
45-64 y
Male
65-74 y
Female
65-74 y
Male
≥75 y 
Female
≥75 y
0.9 4.9 0.0 0.0 0.0 0.4 1.5 0.0
3.0 18.8 0.2 1.7 0.0 0.4 1.5 0.0
2.0 2.7 0.9 1.7 0.4 1.1 0.7 0.4
11.9 22.8 7.6 11.0 11.3 18.2 10.4 11.3
18.4 25.5 19.3 32.1 17.9 23.4 14.2 11.3
18.4 25.5 19.3 32.4 17.9 24.4 14.2 11.3
0.5 0.3 1.5 1.0 5.0 3.6 18.7 27.9
0.6 0.3 1.8 1.0 5.8 3.6 27.6 32.7
1.8 4.3 1.2 4.0 0.8 2.5 3.7 1.3
2.3 7.0 2.4 7.7 2.9 3.6 3.7 4.4
3.9 4.0 4.1 5.5 5.0 8.4 10.4 13.1
3.9 4.2 4.1 5.5 5.0 8.4 10.4 13.1
35.0 59.3 45.2 66.5 67.1 82.9 100.7 92.0
42.1 67.0 57.6 84.5 89.6 106.5 147.7 119.9
1.1 3.3 0.9 2.3 0.0 0.7 0.7 0.9
2.0 4.1 1.8 3.9 0.4 7.6 0.7 6.5
6.6 7.9 4.8 6.0 5.0 8.0 5.2 10.5
6.7 7.9 5.0 6.0 5.0 8.0 5.2 10.5
2.1 2.5 1.2 1.6 1.7 0.7 1.4 0.9
2.2 2.5 1.3 1.6 1.7 0.7 1.4 0.9
0.1 0.3 0.2 0.6 0.4 0.7 0.7 0.4
0.5 2.2 1.7 4.8 2.1 2.5 6.0 5.2
0.6 2.0 2.4 3.1 3.8 2.2 9.7 10.0
0.6 2.2 3.0 3.1 4.6 2.2 9.7 10.0
1.5 1.9 1.4 2.2 1.7 1.5 2.2 3.1
13.0 12.8 21.0 20.0 46.2 39.3 46.3 51.9
15.1 12.4 14.9 13.8 11.3 15.6 17.2 11.8
15.1 12.4 15.0 13.8 11.3 15.6 17.2 11.8
3.8 6.4 6.3 6.9 9.2 6.2 9.0 13.5
8.9 11.7 17.4 16.7 20.8 14.9 53.7 31.8
2.9 3.7 12.2 16.3 14.6 19.3 21.6 18.7
2.9 3.7 12.2 16.3 15.0 19.3 21.6 18.7
0.0 0.0 0.2 0.3 2.9 0.4 4.5 1.7
0.0 0.0 0.4 0.5 5.4 0.7 6.0 3.5
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Table 2. Comparison of Patients Who Visited a Health Care Provider With Those Who Did Not 
(Student’s t Test)
Characteristics
Contact Family Physician Contact Specialist
Contact Alternative 
Health Practitioner
Yes
(n = 417
Mean (SD)
No
(n = 84)
Mean (SD)
P 
Value
Yes
(n = 85)
Mean (SD)
No
(n = 416)
Mean (SD)
P 
Value
Yes
(n = 26)
Mean (SD)
No
(n = 475)
Mean (SD)
P 
Value
Age 49.7 (17.5) 49.7 (15.1) NS 50.1 (19.2) 49.6 (16.7) NS 40.3 (13.3) 50.2 (17.1) <.01
Sexa 0.6 (0.5) 0.6 (0.5) NS 0.7 (0.5) 0.6 (0.5) NS 0.8 (0.4) 0.6 (0.5) NS
Educational level 4.3 (2.0) 4.2 (2.0) NS 4.2 (2.0) 4.3 (2.0) NS 4.8 (2.0) 4.3 (2.0) NS
Disease severityb 12.5 (2.8) 11.2 (2.4) <.01 13.3 (3.3) 12.1 (2.6) <.01 14.0 (3.1) 12.2 (2.7) <.01
Disease duration, 
years
16.7 (15.6) 17.7 (14.7) NS 15.6 (17.6) 17.1 (15.0) NS 21.3 (14.4) 16.1 (15.5) NS
Itchc 3.4 (2.7) 2.0 (2.3) <.01 3.9 (3.0) 3.0 (2.6) <.05 4.8 (2.8) 3.0 (2.6) <.01
Painc 1.6 (2.0) 1.2 (1.7) <.05 1.9 (2.2) 1.5 (1.9) NS 2.7 (2.7) 1.5 (1.9) <.05
Fatiguec 3.2 (2.8) 2.5 (2.6) <.05 3.3 (3.0) 3.1 (2.8) NS 4.3 (2.8) 3.0 (2.8) <.05
DLQId 4.3 (4.9) 2.4 (3.8) <.01 5.6 (5.6) 3.7 (4.5) <.01 10.3 (7.3) 3.7 (4.3) <.01
DLQI = Dermatological Life Quality Index; ISDL = Impact of Skin Disease on Daily Life.
a 0 = male, 1 = female, compared through Pearson’s χ2.
b As measured by ISDL, range, 9-36.
c Assessed with visual analogue scales: 0 = no itch/pain/fatigue; 10 = worst itch/pain/fatigue ever experienced.
d Higher scores indicate lower disease-related quality of life. 
